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The high density lipoprotein (HDL) receptor Scavenger Receptor
BII (SR-BII) is encoded by an alternatively spliced mRNA from the
SR-BI gene and is expressed in various tissues. SR-BII proteindiffers
fromSR-BI only in the carboxyl-terminal cytoplasmic tail, which, as
we showed previously, must contain a signal that confers predomi-
nant intracellular expression and rapid endocytosis of HDL. We
haveshownthatSR-BIImediatesHDLendocytosisthroughaclathrin-
dependent, caveolae-independent pathway. Two candidate amino
acidmotifs were identified in the tail that couldmediate association
with clathrin-containing endocytic vesicles: a putative dileucine
motif at position 492–493 and anoverlapping tyrosine-basedYXXZ
motif starting at position 489. Although substitution of tyrosine at
position 489 with alanine or histidine did not affect endocytosis,
substitution L492A resulted in increased surface binding of HDL
and reduced HDL particle endocytosis. Substitution L493A had a
less dramatic effect. No other regions in the carboxyl-terminal tail
appeared to contain motifs required for HDL endocytosis. Substi-
tutions of leucine at position 492 with the hydrophobic amino acids
valine or phenylalanine also reduced HDL endocytosis, stressing
the importance of leucine at this position. Introducing the SR-BII
YTPLL motif into the carboxyl-terminal cytoplasmic tail of SR-BI
converted SR-BI into an endocytic receptor resembling SR-BII.
These results demonstrated that SR-BII differs from SR-BI in sub-
cellular localization and trafficking and suggest that the two iso-
forms differ in the manner in which they target ligands
intracellularly.
Scavenger Receptor BI (SR-BI),2 a member of the CD36 receptor
family, is considered to be the major receptor for high density lipopro-
teins (HDL) and mediates selective lipid uptake from lipoproteins in a
variety of tissues (1–4). During the selective uptake process, only lipids
are taken up from lipoproteins; apolipoproteins are not degraded (5).
There is uncertainty as towhether the selective uptake process occurs at
the cell surface or during uptake and retro-endocytosis of the ligand. In
polarized cells, such as hepatocytes and transfected Madin-Darby
canine kidney cells, evidence points toward SR-BI-dependent retro-en-
docytosis of at least part of the internalized HDL (6–8), although it is
still unclear whether, or to what extent, endocytosis is required for
selective uptake. In non-polarized cells, such as CHO, COS, and human
embryonic kidney cells, selective uptake appears to occur at the cell
membrane (9–12) and, as shown recently, does not require endocytosis
(13). Furthermore, selective uptake could be observed in artificial mem-
branes containing only purified SR-BI (14).
The SR-BI gene gives rise to at least two mRNA splice variants (15,
16). The SR-BII variant is the main isoform in terms of mRNA levels in
some tissues, exceeding SR-BI mRNA levels by up to 48-fold in brain
cells (17), and protein levels reach 10–15% of SR-BI in the liver (16).
SR-BII immunoreactivity has also been detected in significant amounts
in other tissues, such as testes (18), retinal pigment epithelial cells (19),
and rabbit spleen, where protein levels of SR-BII are relatively high
when compared with SR-BI (20). Interestingly, the SR-BII isoform dif-
fers from SR-BI only in its entirely different, yet highly conserved, cyto-
plasmic carboxyl terminus. We recently showed that the carboxyl ter-
minus of SR-BII must contain a signal that mediates predominantly
intracellular expression in CHO cells and polarized Madin-Darby
canine kidney cells (21). However, through endocytosis, SR-BII medi-
ates the accumulation of significant amounts of ligand intracellularly,
largely within the transferrin-positive endosomal recycling compart-
ment (21). Selective uptake of cholesteryl ether from endocytosed HDL
was rather inefficient, however, and virtually all of the selective uptake
mediated by SR-BII could be accounted for by the surface pool of the
receptor (21). The physiological significance of retro-endocytosis of
lipoproteins via the SR-BII pathway remains unclear.
In this study, we aimed to identify the mechanism by which SR-BII
mediates uptake of lipoproteins as well as the signal in the carboxyl
terminus that is responsible for its endocytic activity. Alignment of pre-
dicted and published SR-BII protein sequences identified two candidate
motifs: a dileucinemotif, whichwas conserved among all species, and an
overlapping tyrosine-based motif, which was less conserved. It was
found that SR-BII endocytosis occurs in a clathrin-dependent, caveolae-
independent fashion. The conserved dileucine motif in the carboxyl
terminus of SR-BII appeared essential for endocytosis, whereas the tyro-
sine residue was not required. No other motifs affecting endocytosis
were found in the carboxyl terminus of SR-BII. Interestingly, introduc-
tion of the dileucine motif into the carboxyl terminus of SR-BI resulted
in endocytosis of SR-BI.
EXPERIMENTAL PROCEDURES
Cell Lines—CHO-A7-based clones expressing similar amounts (21)
of either mouse SR-BI or SR-BII protein (“CHO-SRBI” and “CHO-SR-
BII”) were grown in Ham’s F12 medium supplemented with 5% heat-
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inactivated fetal calf serum, 2 mM L-glutamine, 100 units/ml penicil-
lin-G, 100 mg/liter streptomycin, and 0.25 g/liter Geneticin (all from
Invitrogen). CHO-A7 cells used for transient transfections were main-
tained in the same medium but without Geneticin.
Isolation and Labeling of Ligands—Human HDL3 (d  1.13  1.18
g/ml) was obtained from human plasma (donated by volunteers follow-
ing a protocol approved by the University of Kentucky Internal Review
Board) by KBr density gradient fractionation as described before (22),
dialyzed against 150 mMNaCl, 0.01% EDTA, sterile-filtered, and stored
under nitrogen gas at 4 °C. HDL3 apolipoproteins were labeled by iodi-
nation in presence of 125I (Amersham Biosciences) by the iodine mono-
chloridemethod (23). HDL-associated cholesteryl ester was traced with
non-hydrolyzable [1,2(n)-3H]cholesteryl oleoyl ether (Amersham Bio-
sciences) according to the method of Gwynne and Mahaffee (24), with
the following modifications: [1,2(n)-3H]cholesteryl oleoyl ether was
dried in a 12  75-mm glass borosilicate tube (20 Ci/mg of HDL
protein), after which HDL and partially purified cholesteryl ester trans-
fer protein were added. Following a 16-h incubation at 37 °C, HDL was
refloated by ultracentrifugation at a density of 1.21 g/ml. The size and
apolipoprotein integrity of labeled lipoproteins were verified by SDS-
PAGE and non-denaturing gradient gel electrophoresis. The specific
activity typically ranged between 50–100 and 3–10 dpm/ng of protein
for 125I and 3H, respectively. For microscopy studies, fatty acid-free
albumin or the protein fraction of HDL3 was labeled with Alexa Fluor
488 orAlexa Fluor 568 (Molecular Probes, Eugene,OR) according to the
manufacturer’s instructions.
HDL Cell Association and Selective Uptake—Cell association assays
were performed in radiolabeled lipoprotein-containing medium with
0.5% bovine serum albumin instead of serum as described previously
(16). CHO-A7 cells were seeded on 12-well culture clusters at an initial
density of 1 105 cells/cm2 andwere grown until50% confluencywas
reached. Plasmids were introducedwith FuGENE 6 (RocheDiagnostics;
0.5g DNA and 1.5l FuGENE/well) and were grown for an additional
48 h. Thereafter, the cells were either incubated with double-labeled
HDL3 at 37 °C for indicated times or incubated with double-labeled
HDL3 at 4 °C for 2 h, in the latter case with HEPES-buffered medium.
Medium was removed, and cells were washed four times with ice-cold
buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4) containing albumin (2
mg/ml) followed by two washes in the same buffer without albumin.
Cells were then solubilized in 0.1 N NaOH for 60 min at room temper-
ature, and protein content and radioactivity were measured in this
lysate; 125I represented HDL protein association according to the pro-
tein tracer, and 3H represented cholesteryl ester accumulation, calcu-
lated from cell-associated cholesteryl-ether tracer. The non-iodide, tri-
chloroacetic acid-soluble 125I in cell media corresponding to degraded
125I-apolipoprotein was assayed as described (16). Values are expressed
as apparent HDL protein uptake assuming the uptake of intact holopar-
ticles. This was done to compare association of both tracers on the same
basis. Selective uptake is defined as 3H  (125I cell-associated  125I
degraded) and represents the uptake of cholesteryl ester that cannot be
accounted for by the internalization of intact particles. Receptor-spe-
cific values were calculated as the difference between CHO-SR-Bx and
CHO-A7 values. Selective uptake efficiency was defined as the amount
of selective uptake normalized for total (i.e. surface bound and internal-
ized) cell association of 125I-HDL.
Inhibition of Endocytosis—The formation of clathrin-coated pits was
disrupted by different treatments. Potassium depletion was performed
according to the method of Larkin et al. (25), and the hypertonic shock
treatment, in 40% sucrose, was performed according to the method of
Heuser andAnderson (26). Caveolae-dependent endocytosis was inhib-
ited by preincubating cells for 2 h with serum-free medium containing
200 M genistein (Sigma) (27).
Generation of Point Mutations in SR-Bx—Point mutations were
introduced in the carboxyl terminus of full-length murine SR-BI or
SR-BII cDNA that had been subcloned into pCMV5 or pcDNA5
FRT/TO (Invitrogen). Amino acid substitutions were introduced with
the PCR-based QuikChange kit from Stratagene, using synthetic DNA
oligonucleotides (Integrated DNA Technologies, Coralville, IA) carry-
ing the desiredmutation.Mutants were verified byDNA sequence anal-
ysis, and the predicted protein size (82 kDa) was verified by immuno-
blotting using the Red-1 antibody (16) following transient transfection
into CHO-A7 cells.
Microscopy—CHO-A7 cells were grown on glass coverslips, trans-
fected with FuGENE 6, and maintained for an additional 48 h. The
medium was changed on the morning of the experiment. Fluorescently
labeled ligandwas added directly to themedium, at a final concentration
of 10 g/ml, followed by incubations at 37 °C, 5% CO2 for the indicated
amount of time. Thereafter, cells were washed seven times with cold
phosphate-buffered saline, fixed with 4% paraformaldehyde in phos-
phate-buffered saline (at room temperature), and subsequently
mounted on glass slides with VECTASHIELD mounting medium con-
taining nuclear stain 4,6-diamidino-2-phenylindole (Vector Laborato-
ries). Slides were observed under an Olympus BX51 fluorescence
microscope.
Statistical Analysis—Statistics were calculated with Graphpad’s
Prizm software, using one-way analyses of variance with post-hoc Bon-
ferroni’s test. Statistical significant differences, with p values lower than
0.05, are indicated with asterisks in Figs. 2 and 6.
RESULTS
SR-BII-mediated HDL Endocytosis Occurs via a Clathrin-dependent
Pathway—Previous studies showed that in CHO-SRBI cells, most cell-
associated HDL remains on the cell surface (21). SR-BII, in contrast,
mediated extensive endocytosis of HDL, through a transferrin-positive
pathway (21). To elucidate the endocytic mechanism underlying HDL
FIGURE 1. Effect of disruption of clathrin-coated pit formation onHDL endocytosis.
CHO-SRBI and -SRBII cells were incubated in normal or potassium-depleted medium
according to a previously published procedure (25) and subsequently incubated with
Alexa Fluor-labeled HDL3 for 30min, at 37 °C, fixed in paraformaldehyde, and visualized
by fluorescence microscopy. Non-transfected CHO-A7 cells did not bind Alexa Fluor-
HDL3 (Fig. 5) (Ref. 21 and data not shown).
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uptake by SR-BII, we first studied uptake of HDL, fluorescently labeled
at the proteinmoiety, in CHO-SRBII cells after a short potassiumdeple-
tion treatment to block clathrin-coated pit formation (25). As shown in
Fig. 1, potassiumdepletion led to amarked decrease ofHDL endocytosis
by CHO-SRBII cells. Cells grown in potassium-containing medium,
however, showed intracellular localization of the ligand, as we have
reported before (21). In the case of CHO-SRBI cells, the bulk of cell-
associatedHDLwas found at the cell surface, both in control cells and in
treated cells. Incubation in high sucrose buffer, also known to disrupt
clathrin-coated pit formation (26), had similar results (not shown). For
both receptor isoforms, potassium depletion did not alter 4 °C binding
of 125I-HDL, indicating that the steady-state amount of surface recep-
tors was unaltered by the treatment (Fig. 2A). At 37 °C, however, cell
association (the sumof surface-bound and internalized ligand) in potas-
sium-depleted CHO-SRBII cells was significantly decreased when com-
pared with untreated cells (Fig. 2B). This is in line with an inhibitory
effect of potassiumdepletion on intracellular accumulation ofHDL (Fig.
1). In the case of SR-BI, potassium depletion resulted in a slight but
significant increase in 37 °C cell association. No effect of potassium
depletion on HDL-cell association was seen in receptor-deficient con-
trol cells. Surprisingly, although potassium depletion had little effect on
selective uptake by SR-BI, selective uptake by SR-BII was actually sig-
nificantly increased following the treatment (Fig. 2C), despite unaltered
surface receptor numbers in the steady-state (Fig. 2A). The explanation
for this is unclear. Perhaps the displacement of SR-BII out of clathrin-
coated pits to other areas of the cell surface enhances selective uptake
efficiency. Nevertheless, it can be concluded that blocking SR-BII-de-
pendent HDL endocytosis does not impair selective uptake. Genistein,
an inhibitor of caveolae-dependent uptake (28), had no effect on HDL
uptake by either CHO-SRBI or CHO-SRBII cells (Fig. 3), whereas the
compound potently inhibited uptake of Alexa Fluor-labeled albumin, a
marker for caveolae-dependent endocytosis (29) (Fig. 3).
Tyr-489 Is Not Required for Endocytosis of HDL by SR-BII—Previ-
ously published data showed that deletion of the SR-BI carboxyl termi-
nus did not affect surface expression of SR-BI in CHO cells (21). We
therefore hypothesized that the strongly conserved carboxyl terminus
of SR-BII (16) (Fig. 4)must contain amotif thatmediates receptor endo-
cytosis. Alignment of hitherto known SR-BII cDNA sequences aswell as
SR-BII sequences predicted based on published SR-BI data, shown in
Fig. 4, revealed a putative YXXZ (Z representing a hydrophobic amino
acid) motif (30) at amino acid positions 489–492 with a partially over-
lapping, completely conserved dileucine motif (Leu-492–Leu-493). It
should be noted, however, that, in contrast to the dileucine repeat, the
tyrosine residue is not entirely conserved; in the rabbit, this residue is
replaced with a histidine (20).
Mutagenesis of the carboxyl terminus of SR-BII was carried out to
define amino acid residues necessary for SR-BII-mediated HDL endo-
cytosis. Constructs encoding wild-type SR-BI or SR-BII or mutant iso-
forms were transiently transfected into CHO-A7 cells grown on glass
coverslips. Endocytosis was determined microscopically after incuba-
FIGURE 2. Effect of disruption of clathrin-coated pit formation on HDL cell associa-
tionandselectiveuptake.CHO-SRBI, CHO-SRBII, and control CHO-A7 cellswere treated
with serum-free control medium (open bars) or potassium-depleted medium (dark gray
bars) and then incubated with HDL3 that was labeled at the protein moiety with
125I at
4 °C (A) or at 37 °C (B) or with HDL3 additionally labeled with [
3H]cholesteryl oleoyl ether
at 37 °C (C). Error bars indicate S.D. with n 3; the figure is representative of four inde-
pendent experiments, all with similar outcomes.Asterisks indicate statistically significant
differences in CHO-SRBx cells, control versus potassium-depleted medium.
FIGURE 3. Effect of genistein, an inhibitor of caveolae-dependent endocytosis, on
HDL uptake. CHO cells expressing SR-BI or SR-BII were preincubated in serum-free
medium for 2 h, either with or without 200 M genistein. Thereafter, Alexa Fluor 488-
labeled HDL3 (10g/ml) or Alexa Fluor 488-labeled albumin (10g/ml) was added, and
cells were further incubated for 30 min, fixed, and mounted on a cover slide for fluores-
cence microscopy.
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tionwithAlexa Fluor 568-labeledHDL3 (10g/mlHDLprotein, 40–60
min, 37 °C). Table 1 shows the analyzed mutations and summarizes the
effect of the mutations on HDL endocytosis by SR-BII.
First, it was found that the endocytic signal in the carboxyl terminus
of SR-BII is indeed contained within the YTPLL stretch since the
remainder of the carboxyl terminus could be deleted (deletion of resi-
dues between Pro-469 and Pro-488, not shown; and mutant E494stop,
Fig. 5C) without an apparent effect on the SR-BII phenotype (Table 1).
To address the question of whether Tyr-489 is required for HDL endo-
cytosis by SR-BII, this residue was replaced by histidine or alanine, and
the ability of themutant receptors tomediate endocytosis ofAlexa Fluor
568-labeled HDL3 at 37 °C was studied in transiently transfected
CHO-A7 cells. As shown in Fig. 5D, mutant Y489A still mediated HDL
endocytosis; the same was observed for mutant Y489H (not shown).
Thus, tyrosine 489 appears not to be required for endocytosis of HDL.
The Dileucine Motif Leu-492–Leu-493 Is Required for Intracellular
Accumulation of HDL—Dileucine motifs are known to mediate endo-
cytosis into endosomal compartments (31) and usually correspond to a
(DE)XXXL(LI) or DXXLL consensus. Despite the fact that SR-BII lacks
the acidic residue(s) preceding Leu-492, we nevertheless tested the
hypothesis that the strongly conserved dileucine repeat Leu-492–Leu-
493 is required for SR-BII endocytosis. Interestingly, substitution L492A
resulted in a virtual abolishment of intracellular accumulation of Alexa
Fluor-labeledHDL inCHOcells (Fig. 5E). Substitution L493A had a less
striking effect, with only partial loss of endocytic activity (Fig. 5F),
whereas Thr-490 and Pro-491 appeared not critical for the SR-BII phe-
notype (not shown; Table 1). Further, we tested whether leucine, one of
the most hydrophobic amino acids, is required at position 492 or
whether it can be replaced by another hydrophobic amino acid such as
the structurally similar hydrophobic amino acid valine or by phenylala-
nine, which carries a “bulky” side chain. Interestingly, as seen in Fig. 5G,
CHO cells expressing the L492V mutant accumulated HDL mainly on
the cell surface, not dissimilar from wild-type SR-BI but in strong con-
trast with wild-type SR-BII. The same was observed for L492F (not
shown). Thus, leucine 492 is specifically required for SR-BII endocytosis
and might be part of an unorthodox dileucine motif.
Introduction of the SR-BII Endocytic Motif into SR-BI Results in HDL
Endocytosis—The carboxyl terminus of SR-BI contains a tyrosine resi-
due at position 490 (Table 1), which is highly conserved, and a leucine
residue at position 494. To test whether introduction of the YTPLL
motif into SR-BI would be sufficient to mediate endocytosis, the amino
acids in between Tyr-490 and Leu-494 were substituted with the amino
acid sequence TPL (Table 1). Strikingly, when introduced into CHO
cells, this SR-BI mutant mediated endocytosis of HDL similarly to SR-
BII (Fig. 5H). These results show that the YTPLL residue is sufficient to
mediate endocytosis. Furthermore, since the YTP residues are dispen-
sable for endocytosis by SR-BII, these results strongly suggest that the
dileucine motif is the mediator of endocytosis.
Effect of Mutations in the Carboxyl Terminus of SR-BII on Selective
Uptake Efficiency—To determine whether mutations in the endocytic
motif of SR-BII that block HDL endocytosis also affect selective uptake
efficiency, wild-type SR-BI and SR-BII aswell as variousmutant forms of
these receptors were transfected into CHO-A7 cells. Non-transfected
and transfected cells were then incubated with 125I/3H-labeled HDL3,
and receptor-mediated selective uptake efficiency was determined by
measuring the ratio of selective uptake per unit of cell association. In
agreementwith published results (21), SR-BIImediated selective uptake
from HDL with reduced efficiency when compared with SR-BI (Fig. 6),
most likely due to the fact that HDL endocytosed by SR-BII did not
significantly contribute to selective uptake. All mutants that abolished
HDL endocytosis showed statistically significant increases in selective
uptake efficiencywhen comparedwith SR-BII, reaching similar efficien-
cies as observedwithwild-type SR-BI. Interestingly, two SR-BIImutants
that maintained endocytic capacity, i.e. the Y489A mutant and the
mutant lacking the residues following the endocytic motif (E494stop),
showed increased selective uptake efficiency (Fig. 6) when compared
TABLE 1
Mutational analysis of the carboxyl terminus of SR-BI and SR-BII
The putative endocytosis signal in SR-BII is underlined, point-mutations are in bold. Endocytosis was determined microscopically as shown in Fig. 5.
Amino acid sequence Mutation Endocytosis?
SR-BII
GPEDTISPPNLIAWSDQPPSPYTPLLEDSLSGQPTSAMA SR-BII Yes
GPEDTISPPNLIAWSDQPPSPATPLLEDSLSGQPTSAMA SR-BII Y489A Yes
GPEDTISPPNLIAWSDQPPSPHTPLLEDSLSGQPTSAMA SR-BII Y489H Yes
GPEDTISPPNLIAWSDQPPSPYAPLLEDSLSGQPTSAMA SR-BII T490A Yes
GPEDTISPPNLIAWSDQPPSPYTALLEDSLSGQPTSAMA SR-BII P491A Yes
GPEDTISPPNLIAWSDQPPSPYTPALEDSLSGQPTSAMA SR-BII L492A No
GPEDTISPPNLIAWSDQPPSPYTPVLEDSLSGQPTSAMA SR-BII L492V No
GPEDTISPPNLIAWSDQPPSPYTPFLEDSLSGQPTSAMA SR-BII L492F No
GPEDTISPPNLIAWSDQPPSPYTPLAEDSLSGQPTSAMA SR-BII L493A Yes
GPEDTISPPNLIAWSDQPPSP SR-BII Y489stop No
G---------------------------------YTPLLEDSLSGQPTSAMA SR-BII delP469P488 Yes
GPEDTISPPNLIAWSDQPPSPYTPLL SR-BII E494stop Yes
SR-BI
EKCFLFWSGSKKGSQDKEAIQAYSESLMSPAAKGTVLQEAKL SR-BI No
EKCFLFWSGSKKGSQDKEAIQAYTPLLMSPAAKGTVLQEAKL SR-BI Y490TPLL Yes
FIGURE 4. Alignment of known amino acid
sequences of the SR-BII carboxyl terminus.
Shown are carboxyl termini from human (Ref. 37),
mouse (Refs. 15 and 16) and rabbit (Ref. 20) as well
as from predicted sequences from cow, hamster
(incomplete), swine, and rat (GenBankTM acces-
sion numbers AF019384, U11453, NM213967, and
D89655, respectively.
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with wild-type SR-BII. These results suggest that these mutants deliver
HDL to different cellular compartments than SR-BII and that this allows
for selective uptake to occur.
DISCUSSION
In the present study, we show that SR-BII, a protein encoded by
alternatively spliced SR-BImRNA, undergoes endocytosis by a clathrin-
dependent, caveolae-independentmechanism. Endocytosis appeared to
be mediated by a unique signal in the cytoplasmic carboxyl terminus,
which was identified as a conserved dileucine-motif.
When compared with previously described dileucine motifs, the
putative dileucine motif of SR-BII is somewhat unusual. Although it
carries a serine residue after the dileucine repeat, the motif lacks the
preceding acidic amino acids conforming to the consensus (DE)XXX-
L(LI) or DXXLL (31). These dileucine motifs mediate rapid endocytosis
and generally target the receptor to late endosomes or lysosomes (31).
One example of a protein with such a signal is lysosomal integral mem-
brane protein-II (LIMP-II), which belongs to the same scavenger recep-
tor family as CD36, SR-BI, and SR-BII. However, SR-BII does not appear
to direct HDL to lysosomes since apolipoprotein degradation is negligi-
ble (21). Perhaps the lack of the acidic residues prior to the dileucine
repeat, which might decrease lysosomal targeting efficiency (31, 32),
prevents lysosomal targeting of SR-BII. Interestingly, introduction of
the SR-BII dileucine motif into the carboxyl terminus of SR-BI confers
the SR-BII-like endocytic phenotype to an otherwise unaltered SR-BII,
providing additional evidence that this motif alone is sufficient to target
receptors for internalization.
We previously showed that SR-BII-mediated selective lipid uptake
fromHDL is less efficient than selective uptake by SR-BI and argued that
endocytosed HDL does not contribute significantly to the selective
uptake process (21). Our present data indicate that SR-BII mutants that
are deficient in endocytosis have enhanced selective uptake activity. In
addition, blocking SR-BII-mediated HDL endocytosis by potassium
depletion actually enhanced selective uptake.We interpret these results
to suggest that localization of the receptor to the cell surface is optimal
for selective uptake. SR-BI-dependent endocytosis of HDL has been
reported by various groups (6, 7, 8, 13), but increasing evidence points
against a role for HDL endocytosis in selective uptake. As recently
shown by Nieland et al. (13), for example, blocking of SR-BI-dependent
HDL endocytosis appeared not to inhibit selective uptake, and blocking
of selective uptake by specific inhibitors did not affect endocytosis of
HDL. Furthermore, selective uptake can be mediated by purified SR-BI
inserted into artificial membranes (13), and electron microscopic stud-
ies showed that little HDL is taken up by cells that naturally exhibit
strong SR-BI-dependent selective uptake activities (10, 33). Thus, what-
ever the functional significance of HDL endocytosis by SR-BI or SR-BII,
it does not seem to be related to selective lipid uptake from the lipopro-
tein. HDL endocytosis by SR-BII appears unique in this respect, how-
ever, since mutations in the carboxyl terminus of SR-BII that did not
abolish endocytosis did not show the reduced selective uptake efficiency
characteristic for SR-BII. This is somewhat unexpected and could indi-
cate that endocytosis of HDL does not necessarily preclude selective
uptake. Possibly, the endocytic route taken by wild-type SR-BII is dif-
ferent from mutant SR-BII and targets HDL to compartments where
selective uptake is not efficient.Nevertheless, bothwild-type SR-BII (21)
FIGURE 5. Effect of point mutations in the carboxyl terminus of SR-BI and SR-BII on
HDLuptake.CHOcellswere transfectedwith SR-Bx-encodingplasmids expressingwild-
type SR-BI or SR-BII or with mutant forms of the receptors. 24 h later, the cells were
incubated for 40–60 min with Alexa Fluor 568-labeled HDL3, fixed, and mounted for
fluorescencemicroscopy. Note that for all of the transiently transfected cell populations,
Alexa Fluor 568 HDL is not found associated with cells not expressing SR-Bx. Nuclei (N)
were stained with 4,6-diamidino-2-phenylindole. Arrows point to intracellular ligand,
whereas ligandon the cell surface is indicatedwitharrowheads.A SR-BI;B SR-BII;C
E494stop; D Y489A; E L492A; F L493A; G L492V; H SR-BI YTPLL.
FIGURE 6. Selective uptake efficiency (i.e. selective uptake divided by cell associa-
tion) by CHO cells expressing SR-BI, SR-BII, and indicatedmutants. Shown are aver-
ages S.D. (n 6) obtained by combining values from two independent experiments.
TheefficiencyobtainedwithSR-BII differed significantly fromall other isoforms (p0.05;
Dunnett’smultiple comparison test).Asterisks indicate statistically significantdifferences
between SR-BII and all other receptors.
Mechanism of SR-BII Endocytosis
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and SR-BIImutants that retained endocytic activity (data not shown) do
not degrade significant amounts of HDL apolipoproteins.
Although SR-BII protein levels inmost tissues are relatively lowwhen
compared with SR-BI, it cannot be excluded that some of the severe
occlusive atherosclerosis displayed by SR-BI(II)/ApoE double knock-
out mice (34) can be attributed to lack of SR-BII. It is not likely that
SR-BII plays a role in bulk HDL metabolism, but the isoform might
nevertheless indirectly be involved in cholesterol homeostasis. SR-BII
recyclesHDL in a transferrin-positive peri-centriolar compartment (21)
close to the nucleus. HDL carries many biologically active hydrophobic
compounds that are ligands for nuclear receptors, including oxysterols,
fat-soluble vitamins, estrogens, and bile salts, compounds that normally
have to diffuse across the plasmamembrane and through the cytoplasm
to reach the nucleus. Perhaps efficient internalization and peri-nuclear
recycling of HDL by SR-BII enhances diffusion of such compounds into
the nucleus and thus potentiates the cellular response; this is a possibil-
ity we are currently investigating. Additionally, SR-BII-mediated retro-
endocytosis of HDL, a potent acceptor of free cholesterol, might affect
the endocytic recycling compartment itself by altering its cholesterol
content, thus potentially affecting endocytic pathways of other recep-
tors. Recycling of glycosylphosphatidylinositol-anchored receptors, for
example, strongly depends on endosomal cholesterol content (35, 36).
Taken together, we have identified an endocyticmotif in the carboxyl
terminus of SR-BII thatmediates clathrin-dependent endocytosis of the
receptor and have provided additional evidence against involvement of
HDL endocytosis in selective uptake.
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